Cardiac performance is limited by oxygen delivery to the mitochondria in the crystalloid-perfused working heart

Sarah Kuzmiak-Glancy1,2, Raúl Covian2, Armel N Femnou1,2

  • 1Department of Biomedical Engineering, The George Washington University , Washington, District of Columbia.

Insights

Crystalloid-perfused hearts show oxygen-limited cardiac function. Adding oxygen-carrying perfluorocarbons (PFCs) improves myocardial oxygen delivery, mitochondrial function, and cardiac performance, creating a more physiological state.

Area of Science:

  • Cardiovascular Physiology
  • Biochemistry
  • Biomedical Engineering

Background:

  • Crystalloid-perfused working heart models are crucial for studying cardiac function and pharmacology.
  • Oxygen delivery limitations in these models can affect myocardial function, particularly concerning myoglobin oxygenation and oxidative phosphorylation (OxPhos).
  • The impact of reduced myoglobin oxygen saturation on OxPhos remains unclear due to myoglobin's lower oxygen affinity compared to cytochrome c oxidase (COX).

Purpose of the Study:

  • To develop an affordable perfluorocarbon (PFC) emulsion for enhanced perfusate oxygen carrying capacity.
  • To investigate the effects of PFC supplementation on myocardial oxygenation, mitochondrial redox state, and cardiac function in a left ventricular working heart model.
  • To determine if oxygen delivery limitations impact oxidative phosphorylation and cardiac performance in crystalloid-perfused hearts.

Main Methods:

  • Laboratory synthesis of an affordable perfluorocarbon (PFC) emulsion.
  • Utilizing a left ventricular working heart model perfused with either Krebs-Henseleit (KH) buffer or KH supplemented with PFC.
  • Monitoring cardiac function, metabolic rate, myoglobin oxygenation, and mitochondrial cytochrome redox state using transmural illumination optical absorbance spectroscopy.

Main Results:

  • PFC supplementation increased perfusate oxygen carrying capacity by 3.6-fold.
  • In KH-perfused hearts, myoglobin was deoxygenated and mitochondrial cytochromes were highly reduced, indicating cytoplasmic and OxPhos hypoxia.
  • PFC perfusate significantly increased aortic output, oxygen consumption, myoglobin oxygenation, and oxidized mitochondrial cytochromes, improving cardiac work over a wider range of perfusate oxygen levels.

Conclusions:

  • The commonly used crystalloid-perfused working heart model is limited by oxygen delivery to mitochondria, impacting oxidative phosphorylation and cardiac work.
  • Supplementation with oxygen-carrying PFCs effectively reverses mitochondrial hypoxia by enhancing myocardial oxygen delivery.
  • PFCs improve cardiac performance and establish a more physiological mitochondrial redox state, highlighting the critical role of oxygen delivery in modulating cardiac function.

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.7K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
608
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
Cardiac Output I:Effect of Heart Rate on Cardiac Output01:19

Cardiac Output I:Effect of Heart Rate on Cardiac Output

Cardiac Output
Cardiac output (CO) refers to the total amount of blood ejected by one of the ventricles in liters per minute (L/min). In a resting adult, CO ranges from 5 to 6 L/min, adjusting according to the body's metabolic requirements.
Effect of Heart Rate on Cardiac Output
Cardiac output adapts to metabolic demands during stress, physical activity, or illness. The autonomic nervous system regulates heart rate via the sinoatrial node. The parasympathetic nervous system decreases heart...
2.8K